Turnstone announces Burgess’ move to executive chairman alongside pair of promotions; plus Fulgent, Centene FDS, Akouos and more

Turnstone Biologics Inc. President of R&D Mike Burgess will become executive chairman of R&D. The cancer immunotherapy company also promoted José Otero to CTO from SVP of technical operations and Saryah Azmat to CBO from SVP of business development and corporate strategy.

Genetic diagnostics company Fulgent Genetics Inc. (NASDAQ:FLGT) hired Lawrence Weiss as CMO. Weiss was CMO at NeoGenomics Inc. (NASDAQ:NEO). ...